363 related articles for article (PubMed ID: 21451433)
1. Induction of podocyte-derived VEGF ameliorates podocyte injury and subsequent abnormal glomerular development caused by puromycin aminonucleoside.
Ma J; Matsusaka T; Yang HC; Zhong J; Takagi N; Fogo AB; Kon V; Ichikawa I
Pediatr Res; 2011 Jul; 70(1):83-9. PubMed ID: 21451433
[TBL] [Abstract][Full Text] [Related]
2. GIV/girdin links vascular endothelial growth factor signaling to Akt survival signaling in podocytes independent of nephrin.
Wang H; Misaki T; Taupin V; Eguchi A; Ghosh P; Farquhar MG
J Am Soc Nephrol; 2015 Feb; 26(2):314-27. PubMed ID: 25012178
[TBL] [Abstract][Full Text] [Related]
3. Adrenomedullin ameliorates podocyte injury induced by puromycin aminonucleoside in vitro and in vivo through modulation of Rho GTPases.
Dong N; Meng L; Xue R; Yu M; Zhao Z; Liu X
Int Urol Nephrol; 2017 Aug; 49(8):1489-1506. PubMed ID: 28528353
[TBL] [Abstract][Full Text] [Related]
4. Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats.
Okada T; Sakaguchi T; Hatamura I; Saji F; Negi S; Otani H; Muragaki Y; Kawachi H; Shigematsu T
Clin Exp Nephrol; 2009 Oct; 13(5):438-446. PubMed ID: 19452240
[TBL] [Abstract][Full Text] [Related]
5. Acute podocyte vascular endothelial growth factor (VEGF-A) knockdown disrupts alphaVbeta3 integrin signaling in the glomerulus.
Veron D; Villegas G; Aggarwal PK; Bertuccio C; Jimenez J; Velazquez H; Reidy K; Abrahamson DR; Moeckel G; Kashgarian M; Tufro A
PLoS One; 2012; 7(7):e40589. PubMed ID: 22808199
[TBL] [Abstract][Full Text] [Related]
6. Triptolide protects podocytes from puromycin aminonucleoside induced injury in vivo and in vitro.
Zheng CX; Chen ZH; Zeng CH; Qin WS; Li LS; Liu ZH
Kidney Int; 2008 Sep; 74(5):596-612. PubMed ID: 18509322
[TBL] [Abstract][Full Text] [Related]
7. Nck proteins maintain the adult glomerular filtration barrier.
Jones N; New LA; Fortino MA; Eremina V; Ruston J; Blasutig IM; Aoudjit L; Zou Y; Liu X; Yu GL; Takano T; Quaggin SE; Pawson T
J Am Soc Nephrol; 2009 Jul; 20(7):1533-43. PubMed ID: 19443634
[TBL] [Abstract][Full Text] [Related]
8. Preservations of nephrin and synaptopodin by recombinant hepatocyte growth factor in podocytes for the attenuations of foot process injury and albuminuria in nephritic mice.
Kato T; Mizuno S; Nakamura T
Nephrology (Carlton); 2011 Mar; 16(3):310-8. PubMed ID: 21342325
[TBL] [Abstract][Full Text] [Related]
9. Hirudin attenuates puromycin aminonucleoside-induced glomerular podocyte injury by inhibiting MAPK-mediated endoplasmic reticulum stress.
Long C; Lin Q; Mo J; Xiao Y; Xie Y
Drug Dev Res; 2022 Jun; 83(4):1047-1056. PubMed ID: 35277865
[TBL] [Abstract][Full Text] [Related]
10. Forced expression of vascular endothelial growth factor-A in podocytes decreases mesangial cell numbers and attenuates endothelial cell differentiation in the mouse glomerulus.
Suyama M; Miyazaki Y; Matsusaka T; Sugano N; Ueda H; Kawamura T; Ogura M; Yokoo T
Clin Exp Nephrol; 2018 Apr; 22(2):266-274. PubMed ID: 28776225
[TBL] [Abstract][Full Text] [Related]
11. 1,25-Dihydroxyvitamin D(3) prevents puromycin aminonucleoside-induced apoptosis of glomerular podocytes by activating the phosphatidylinositol 3-kinase/Akt-signaling pathway.
Xiao H; Shi W; Liu S; Wang W; Zhang B; Zhang Y; Xu L; Liang X; Liang Y
Am J Nephrol; 2009; 30(1):34-43. PubMed ID: 19202327
[TBL] [Abstract][Full Text] [Related]
12. Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.
Fuchshofer R; Ullmann S; Zeilbeck LF; Baumann M; Junglas B; Tamm ER
Histochem Cell Biol; 2011 Sep; 136(3):301-19. PubMed ID: 21814837
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of markers of podocyte injury in the rat puromycin aminonucleoside nephropathy model.
Kakimoto T; Okada K; Fujitaka K; Nishio M; Kato T; Fukunari A; Utsumi H
Exp Toxicol Pathol; 2015 Feb; 67(2):171-7. PubMed ID: 25481214
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal Stromal Cells Induce Podocyte Protection in the Puromycin Injury Model.
Ornellas FM; Ramalho RJ; Fanelli C; Garnica MR; Malheiros DMAC; Martini SV; Morales MM; Noronha IL
Sci Rep; 2019 Dec; 9(1):19604. PubMed ID: 31862892
[TBL] [Abstract][Full Text] [Related]
15. Close relations between podocyte injuries and membranous proliferative glomerulonephritis in autoimmune murine models.
Kimura J; Ichii O; Otsuka S; Sasaki H; Hashimoto Y; Kon Y
Am J Nephrol; 2013; 38(1):27-38. PubMed ID: 23817053
[TBL] [Abstract][Full Text] [Related]
16. Synaptic vesicle protein 2B is expressed in podocyte, and its expression is altered in proteinuric glomeruli.
Miyauchi N; Saito A; Karasawa T; Harita Y; Suzuki K; Koike H; Han GD; Shimizu F; Kawachi H
J Am Soc Nephrol; 2006 Oct; 17(10):2748-59. PubMed ID: 16943307
[TBL] [Abstract][Full Text] [Related]
17. IL-1 receptor signaling in podocytes limits susceptibility to glomerular damage.
Ren J; Lu X; Hall G; Privratsky JR; Robson MJ; Blakely RD; Crowley SD
Am J Physiol Renal Physiol; 2022 Feb; 322(2):F164-F174. PubMed ID: 34894725
[TBL] [Abstract][Full Text] [Related]
18. Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models.
Shen X; Jiang H; Ying M; Xie Z; Li X; Wang H; Zhao J; Lin C; Wang Y; Feng S; Shen J; Weng C; Lin W; Wang H; Zhou Q; Bi Y; Li M; Wang L; Zhu T; Huang X; Lan HY; Zhou J; Chen J
Sci Rep; 2016 Sep; 6():32087. PubMed ID: 27580845
[TBL] [Abstract][Full Text] [Related]
19. Receptor activator of NF-kappaB and podocytes: towards a function of a novel receptor-ligand pair in the survival response of podocyte injury.
Liu S; Shi W; Xiao H; Liang X; Deng C; Ye Z; Mei P; Wang S; Liu X; Shan Z; Liang Y; Zhang B; Wang W; Liu Y; Xu L; Xia Y; Ma J; Li Z
PLoS One; 2012; 7(7):e41331. PubMed ID: 22848465
[TBL] [Abstract][Full Text] [Related]
20. Partial podocyte replenishment in experimental FSGS derives from nonpodocyte sources.
Kaverina NV; Eng DG; Schneider RR; Pippin JW; Shankland SJ
Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1397-413. PubMed ID: 27076646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
